Vol. 273, Issue 6, H2539-H2548, December 1997
-Adrenoceptor-coupled Gs
protein facilitates the activation of cAMP-dependent cardiac
Cl
current
Siegried
Pelzer,
Yongdong
You,
Yaroslav M.
Shuba, and
Dieter J.
Pelzer
Membrane Transport and Signaling Group, Department of Physiology and
Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada B3H
4H7
 |
ABSTRACT |
Here a comparison is made between adenosine
3',5'-cyclic monophosphate (cAMP)-activated
Cl
current
(ICl) density
and activation time course in response to
-adrenoceptor stimulation
with isoproterenol and adenylyl cyclase activation with
forskolin. Saturating concentrations of isoproterenol and forskolin
failed to activate an
ICl in guinea pig
atrial as well as in rat and frog ventricular cardiomyocytes. In guinea
pig ventricular cardiomyocytes, step application of 1 µM
isoproterenol induced an
ICl
of
0.89 ± 0.32 pA/pF (holding potential
40 mV, temperature 22 ± 1°C).
ICl activation
started after 3 ± 1 s, was complete within 44 ± 9 s, and was
abolished after cell dialysis with the Rp diastereomer of adenosine
3',5'-cyclic monophosphothioate. Stimulation with
increasing concentrations of forskolin (0.01-10 µM) increased
ICl density and
accelerated ICl
activation. With 1 µM forskolin,
ICl density was
maximal (
0.57 ± 0.30 pA/pF) but significantly smaller than
that achieved with 1 µM isoproterenol. Although
ICl density could
not be further augmented by forskolin >1 µM, current activation
(latency 28 ± 8 s, full activation after 112 ± 8 s
with 1 µM forskolin) was further accelerated by 3 and 10 µM
forskolin. However,
ICl activation with 10 µM forskolin was still slower than that with 1 µM
isoproterenol. A low isoproterenol concentration (1 nM), which did not
activate ICl by
itself, accelerated the 1 µM forskolin-induced activation of
ICl by 35%; this
speeding up was abolished after cell dialysis with guanosine
5'-O-(2-thiodiphosphate).
ICl deactivation
after the washout of 1 µM forskolin or 1 µM isoproterenol followed
a similar time course. After stimulation with 10 µM forskolin or 1 µM forskolin + 1 µM isoproterenol, but not with 1 µM forskolin + 1 nM isoproterenol, the decay of
ICl was
significantly delayed. These results indicate that both cAMP-dependent
and cAMP-independent G protein pathways contribute to the regulation of
guinea pig ventricular
ICl.
heart; chloride current; adenylyl cyclase; adenosine
3',5'-cyclic monophosphate
 |
INTRODUCTION |
ACTIVATION OF the
-adrenoceptor-linked stimulatory
guanosine nucleotide-binding protein
(Gs) (7) is a key event in the modulation of cardiac membrane currents by sympathetic stimulation (cf.
Ref. 9). Ionic current regulation is generally ascribed to enhanced
adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphorylation of channel proteins by protein kinase A (PKA; e.g.,
Ref. 5) after
-adrenoceptor activation of
Gs and
Gs activation of the adenylyl
cyclase (AC)-cAMP-PKA cascade (cf. Ref. 7). This slow cytoplasmic
cascade of reactions has been invoked to explain the stimulation of the
L-type Ca2+ current
(ICa; 20),
pacemaker current (4), and delayed rectifier K+ current (32) by
-adrenoceptor agonists as well as their inhibitory effects on the
Na+ current
(INa; 23).
Additionally,
-adrenoceptor-activated
Gs also seems to have a fast,
membrane-delimited, cAMP-independent action on
ICa (20),
pacemaker current (31), and
INa (25).
In guinea pig ventricular and other mammalian cardiac tissues,
-adrenoceptor agonists also activate a time- and voltage-independent Cl
current
(ICl; e.g., Refs.
2, 10, 12, 19), which seems to play an important role in the regulation
of action potential duration and resting membrane potential in these
cells (cf. Ref. 11). Current activation seems to require PKA-mediated
phosphorylation as well as nucleotide binding and nucleotide hydrolysis
(see Ref. 6) and is curtailed by dephosphorylation by okadaic
acid-sensitive and okadaic acid-insensitive phosphatases (14). The
contribution of membrane-delimited, cAMP-independent
Gs pathways to the regulation of
ICl is not
entirely clear. Although Hwang et al. (15) failed to find evidence for
direct Gs modulation of
ICl, Kozlowski et al. (18) reported that nonhydrolyzable GTP analogs accelerated ICl activation in
response to photolysis of caged cAMP.
The objective of this study was to further characterize the role of
Gs in
ICl regulation.
To this end, we compared
ICl magnitude as
well as ICl
activation and deactivation time courses after
-adrenoceptor
activation by isoproterenol (Iso) and AC stimulation by forskolin (Fsk)
in guinea pig ventricular cardiomyocytes. Iso or Fsk was step applied
by a rapid perfusion technique (cf. Ref. 24). We found that Fsk
increased steady-state
ICl and
accelerated ICl
activation in a concentration-dependent manner. The decay of
ICl after agonist
removal was little affected by variations in the Fsk concentration;
however, with supramaximal concentrations (>1 µM Fsk), the delay
between agonist washout and the onset of ICl decay was
significantly prolonged. Stimulation of
Gs with 1 µM Iso elicited an
ICl that
activated faster and was larger in size than the maximal
ICl induced by
direct stimulation of AC with Fsk. However, Iso failed to augment
ICl activated by
1 µM Fsk, and current activation by both Iso and Fsk was abolished when cAMP-dependent phosphorylation was inhibited. Threshold
stimulation of
-adrenoceptor-coupled
Gs protein by 1 nM Iso, which was
not sufficient to induce a detectable
ICl, accelerated
the Fsk-induced activation of
ICl but did not
alter ICl
magnitude and ICl
deactivation time course. The effect of low Iso was abolished by cell
dialysis with guanosine
5'-O-(2-thiodiphosphate)
(GDP
S). We conclude that cAMP-independent
Gs protein pathways do not
activate ICl but
enhance cAMP-mediated current activation in guinea pig ventricular
heart cells. Attempts to duplicate the above observations in
cardiomyocytes from guinea pig atrium, where the presence of a small
cAMP-activated ICl had been
reported (17), failed because cAMP-activated
ICl could not be
detected in this preparation. cAMP-activated
ICl was also
found to be absent in cardiomyocytes from rat and frog ventricles.
 |
MATERIALS AND METHODS |
Cell preparation. Single ventricular
myocytes from adult guinea pig, rat (Sprague-Dawley), and frog
(Rana pipiens) hearts were
enzymatically dissociated by a previously described method (21) with
Yakult collagenase (0.1 mg/ml for guinea pig and rat, 0.2 mg/ml for
frog) and stored in a
high-K+-low-Na+
solution (16). Atrial myocytes from guinea pigs were isolated as
described by Wu et al. (33). After digestion of the heart, the atria
were removed, minced, and further digested in a shaker bath at 37°C
with an enzyme solution containing 0.1 mg/ml of dispase, 0.12 mg/ml of
trypsin, 0.32 mg/ml of collagenase (type II), and 2.12 mg/ml of
albumin. The cells were harvested from the supernatant at 15-min
intervals, resuspended in a solution containing (in mM) 1.1 CaCl2, 127 NaCl, 4.6 KCl, 1.1 MgSO4, 2 Na-pyruvate, 10 glucose,
10 creatine, 20 taurine, 5 ribose, 0.01 adenine, 5 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), and 0.1 allopurinol, pH 7.4, and maintained at room temperature.
Solutions and chemicals. The cells
were superfused with an extracellular solution containing (in mM) 140 or 105 NaCl (frog), 5.4 CsCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose,
pH 7.4 with NaOH, and dialyzed via a patch pipette with a solution
containing (in mM) 50 CsCl, 80 or 60 Cs-aspartate (frog), 1 MgCl2, 5 Mg-ATP, 1 Na2-GTP, 10 ethylene
glycol-bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic acid, and 10 HEPES, pH 7.4 with CsOH. For measurements of
Cl
selectivity,
Cl
in the dialysate was
partially substituted for by aspartate. In experiments designed to
inhibit G protein activation (3), the pipette solution was supplemented
with 0.1 mM GDP
S (Na2-GTP was
omitted). To inhibit cAMP-dependent phosphorylation, the Rp diastereomer of adenosine 3',5'-cyclic monophosphothioate
(Rp-cAMPS; 0.1 mM; 26) was added to the pipette solution (Mg-ATP was
omitted). Iso (1 mM stock in ascorbic acid-containing
H2O solution) and Fsk (10 mM stock
in dimethyl sulfoxide) were added in appropriate amounts singly or in
combination to the extracellular solution. Dimethyl sulfoxide (up to
0.1%) had no effect on
ICl and
ICa.
Electrophysiology and concentration-clamp
method. Isolated cardiomyocytes were transferred to the
recording chamber and continuously superfused with the extracellular
solution at room temperature (22 ± 1°C). Low-resistance patch
pipettes (1-3 M
) were prepared in the usual two-step process
(8). After gigaseal formation and patch breakthrough, voltage clamp was
established by an EPC 9 amplifier controlled by an Atari Mega 4 computer with the E9SCREEN acquisition software (Heka,
Lamprecht/Pfalz). Current was measured 1) at a holding potential of
40 mV; 2) during voltage
ramps (ramp speed 1 V/s) consisting of three phases: a
depolarizing phase from the holding potential of
40 to +80 mV, a
hyperpolarizing phase to
80 mV, and a return to the holding
potential; and 3) during 200-ms
voltage pulses applied from
40 mV to various test potentials at
0.1-0.33 Hz. Cell capacitance was determined with software
routines incorporated in E9SCREEN as the time integral of the
capacitive current surge measured in response to 5-mV hyperpolarizing steps from a holding potential of
40 mV after correction for series resistance. Currents and
voltages were recorded on Atari Megafile 44 disks and analyzed with the
Atari data-analysis software 3.11 (Instrutech, Elmont, NY).
ICl was
determined as the Iso- or Fsk-induced change in current under
conditions expected to minimize contaminating currents
(K+ currents were inhibited by
replacement of external and internal K+ by
Cs+,
INa and T-type
ICa were
inactivated by the
40-mV holding potential, and L-type
ICa was blocked
by 1 mM CdCl2 added to the
superfusate). Current density (in pA/pF) is expressed as the ratio of
agonist-induced change in current and cell capacitance (90-170
pF). Rapid applications of Iso and Fsk were produced by an
electronically operated multibarrel microperfusion system (24) that
allows the complete exchange of extracellular solution around heart
cells within <30 ms.
Data are expressed as means ± SD. Statistical significance was
assessed with the unpaired, two-tailed
t-test.
 |
RESULTS |
cAMP-dependent ICl in guinea pig
ventricular cardiomyocytes.
Figure 1 demonstrates the effect of step
applications of Iso and Fsk on the background current in guinea pig
ventricular heart cells. At a holding potential of
40 mV, a
saturating concentration of Iso (1 µM) consistently induced a
substantial inward holding current (Fig.
1Aa). Current activation by Iso
was abolished when cAMP-dependent phosphorylation was inhibited by cell
dialysis with 0.1 mM Rp-cAMPS (Fig.
1Ab). A threshold concentration of Iso (1 nM), which has been reported to exert Rp-cAMPS-resistant, GDP
S-sensitive effects on
ICa in guinea pig
ventricular cardiomyocytes (cf. Ref. 24), had no detectable effect on
the holding current (see Fig.
1Ac). Fsk (1 µM) mimicked the
effect of Iso in generating an inward holding current (Fig.
1Ad); however, in response to stimulation of AC with Fsk, the current activated slower and reached a
smaller steady-state amplitude than that activated by
-adrenoceptor stimulation with Iso. At a holding potential of
40 mV, current activation with 1 µM Iso was preceded by a latency of 3 ± 2 s and
reached 50 and 95% completion in 16 ± 3 and 44 ± 9 s,
respectively (Fig. 1B). After
exposure of the myocytes to 1 µM Fsk, current activation was
detectable after a latency of 28 ± 8 s and reached 50 and 95%
completion only after 62 ± 13 and 112 ± 8 s, respectively (Fig.
1B). The average steady-state
current activated by 1 µM Fsk (
0.57 ± 0.30 pA/pF, Fig. 1B,
inset) was significantly smaller than the current activated by 1 µM Iso (
0.89 ± 0.32 pA/pF;
P = 0.005). However, 1 µM Iso failed
to further augment the current stimulated by 1 µM Fsk (Fig.
1C).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of isoproterenol (Iso) and forskolin (Fsk) on holding current in
guinea pig ventricular myocytes. A:
chart recordings of holding current at 40 mV. Arrows, rapid
application of 1 µM Iso (a), 1 µM Iso after block of protein kinase A by cell dialysis with 0.1 mM
Rp diastereomer of adenosine 3',5'-cyclic
monophosphothioate (Rp-cAMPS; b), 1 nM Iso (c), and 1 µM Fsk
(d). Dashed line, 0-current level.
B: normalized average time course of
changes in holding current
I/Imax at 40 mV
in response to rapid application at 0 time of 1 µM Iso
(n = 9 myocytes) or 1 µM Fsk
(n = 10 myocytes). Horizontal and
vertical lines, SDs of time and current density, respectively, at 50%
activation. Current activation with Iso is significantly faster
(P < 0.0001).
Inset, average steady-state density of
holding current activated by 1 µM Iso
(n = 14 myocytes) and 1 µM Fsk
(n = 21 myocytes). Iso activates
significantly more current than Fsk (P = 0.005). All data in Figs. 1-8 are from a 1st exposure of cells to
agonist. C: current density recorded
at 40 and +40 mV.
|
|
Iso- and Fsk-induced background current was time independent (data not
shown) and showed outward rectification (Figs.
2A and 3A),
and its reversal potential
(Erev) depended
on the transmembrane Cl
gradient. Reduction of the intracellular
Cl
concentration
([Cl
]i)
from 120 to 22 mM caused a negative shift of
Erev (compare Fig. 2A,
a and
b) and an enhanced rectification, as
expected if this current is carried through a
Cl
-selective cardiac ion
channel. The deviation of
Erev from the calculated Cl
potential at
low
[Cl
]i
(see Fig. 2B) is in line with a
moderate permeability of cardiac Cl
channels for aspartate
(cf. Ref. 30), which was used to replace Cl
in the intracellular
solution. The relationship between
[Cl
]i
and the experimentally determined
Erev (see Fig.
2B) was well described by the
Goldman equation, with an
aspartate-to-Cl
permeability ratio of 0.17. This is somewhat higher than the permeability ratio reported by others (cf. Ref. 30), which indicates that the junction potential between the pipette and bath solutions may
partially account for the discrepancy between the
Erev and the
Cl
potential. The
background conductance in the absence of Fsk or Iso was not
significantly altered by variations in
[Cl
]i
(compare Fig. 2A,
a and
b). Thus the basal
Cl
conductance in guinea
pig ventricular cardiomyocytes is low, and Iso- or Fsk-induced changes
in holding current mainly represent cAMP-activated
ICl (cf. Ref.
15).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Cl -sensitive nature of
Fsk-induced current. A:
current-voltage
(I-V)
relationships recorded from cells superfused with extracellular
solution containing 150 mM
Cl and dialyzed with
solution containing 120 (a) or 22 mM
Cl
(b) before (control), during, and
after (washout) exposure to 1 µM Fsk.
Erev, reversal
potential of Fsk-induced current;
[Cl ]e,
extracellular Cl
concentration;
[Cl ]i,
intracellular Cl
concentration. B: dependence of
Erev on
[Cl ]i
in 150 mM extracellular Cl
solution. Solid line, fit of data points (from Figs.
2A and
3A) by the Goldman equation with an
aspartate-to-Cl -permeability
ratio of 0.17; dotted line, relationship between
Erev and
[Cl ]i
as calculated with the Goldman equation for a pure
Cl conductance.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Dependence of steady-state
ICl density and
ICl activation
time course on concentration of Fsk.
A: averaged
I-V
relationships of
ICl recorded from
cells under standard conditions in response to stimulation with 0.03 µM Fsk (n = 3 myocytes),
0.3 µM Fsk (n = 4 myocytes), 1 µM
Fsk (n = 4 myocytes), 3 µM Fsk
(n = 3 myocytes), and 10 µM Fsk
(n = 5 myocytes).
B: dose-response relationship for Fsk
and ICl density
at 40 ( ) and +40 mV ( ). Each point represents average
ICl density
measured in 3-10 cells. Smooth curve, least-squares fit of data at
40 mV with the Hill equation with a half-maximal concentration
of Fsk of 0.39 ± 0.03 mM and a Hill coefficient of 2.43 ± 0.55. C: correlation between time of
half-maximal activation of
ICl
( 1/2) and concentration of
Fsk determined at 40 mV.
|
|
Dependence of ICl on the concentration of
Fsk.
To examine why the stimulation of AC with 1 µM Fsk was less efficient
in activating ICl
than
-adrenoceptor stimulation with 1 µM Iso (see Fig.
1B), we next determined the
dependence of ICl density, ICl
activation time course, and
ICl deactivation
on the concentration of Fsk. Figure 3A
shows averaged current-voltage (I-V)
relationships of
ICl induced by
different concentrations of Fsk. Over a potential range from
80
to +80 mV, 0.03 µM Fsk mostly failed to activate
ICl. Significant
current activation occurred with 0.3 µM Fsk. With 1 µM Fsk,
ICl density was
maximal and indistinguishable from that obtained with 3 and 10 µM
Fsk. The relationship between Fsk concentration and current density at
40 mV was identical to that at +40 mV (Fig.
3B) and well fitted by a Hill
equation with a coefficient of ~2 and a half-maximal concentration of
0.39 µM.
The time course of
ICl activation
was also markedly dependent on the concentration of Fsk (Fig.
3C). The time of half-maximal current activation (
1/2)
decreased from
1/2 = 179 ± 49 s with 0.3 µM Fsk to
1/2 = 32 ± 6 s with 10 µM Fsk. The acceleration of
ICl activation
was most pronounced at Fsk concentrations between 0.3 and 1 µM, where
it was accompanied by an increase in
ICl density (see
Fig. 3B). However, higher Fsk
concentrations that did not further increase
ICl density
further accelerated the activation of
ICl.
Figure 4A
shows examples of
ICl deactivation
after the washout of 0.6, 1, and 10 µM Fsk. At all concentrations,
ICl decay started
only after a considerable delay. The most prominent effect was a
prolongation of this delay by the highest Fsk concentration. On
average, after the washout of 0.6 µM Fsk, a concentration that activated ~75% of maximal steady-state
ICl, current
decay started after a delay 67 ± 11 s (Fig.
4B,
left) and was half-maximal after another 65 ± 9 s (Fig. 4B,
right). When maximal
ICl had been
activated with 1 µM Fsk, the delay to the onset of
ICl decay (88 ± 33 s) as well as the time of half-maximal current decay (76 ± 14 s) were not significantly different. With 10 µM Fsk,
ICl deactivation was much slower than after the washout of 1 µM Fsk, mostly due to a
threefold increase in the delay to the onset of
ICl decay (255 ± 49 s; Fig. 4B,
left) rather than to changes in
ICl decay (
1/2 = 120 ± 45 s; Fig. 4B,
right). This suggests that AC
stimulation with 10 µM Fsk elevates cellular cAMP levels well above
the concentration required to activate maximal steady-state
ICl, which is
already reached with 1 µM Fsk. During the time the 10 µM
Fsk-induced extra cAMP increment is being hydrolyzed,
ICl remains fully
activated. Thus the delay to the onset of
ICl decay is
prolonged by the time it takes for cell cAMP to decrease to the level
achieved by stimuation with 1 µM Fsk.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Dependence of ICl
deactivation on concentration of Fsk.
A: time course of
ICl deactivation
in 3 myocytes after withdrawal of 0.6, 1, and 10 µM Fsk at 0 time.
ICl was measured
at +40 mV and normalized to
ICl density at
time of Fsk withdrawal. B: average
delay between Fsk withdrawal and onset of
ICl decay
(left) and average time of
half-maximal ICl
decay ( 1/2 measured from onset
of current decay; right) with 0.6 (n = 3 myocytes), 1 (n = 5 myocytes), and 10 µM Fsk
(n = 6 myocytes).
|
|
Effect of
-adrenoceptor-coupled
Gs on Fsk activation of
ICl.
Low concentrations of Iso (~1 nM) that have been reported to exert
Rp-cAMPS-resistant, GDP
S-sensitive effects on
ICa (cf. Ref. 24)
did not induce detectable activation of
ICl (see Fig. 1Ac) nor did the application of 1 µM Iso when cAMP-dependent phosphorylation was inhibited (see Fig.
1Ab). On the other hand,
cAMP-mediated activation of both
ICa and
ICl was found to
be accelerated by nonhydrolyzable GTP analogs (18). To further examine
the role of
-adrenoceptor-coupled
Gs in the regulation of
ICl, we studied the effect of 1 nM Iso on Fsk-induced
ICl. The
recordings in Fig. 5A show
that ICl on step
application of 1 µM Fsk (top)
activated slower than if applied together with 1 nM Iso
(bottom). In all myocytes examined,
the coapplication of low Iso had no significant effect on the size of
ICl (Fig.
5B) but accelerated the 1 µM
Fsk-induced activation of
ICl by ~35%
(Fig. 5C; times to current onset and to 50 and 95% activation being 19 ± 6, 42 ± 11, and 74 ± 10 s, respectively), an effect that was not observed when 1 nM Iso was coapplied with 10 µM Fsk (see Fig.
5C,
inset;
n = 4 myocytes).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of low concentrations of Iso on activation of
ICl by Fsk in
guinea pig ventricular myocytes. A:
chart recordings of
ICl (at 40
mV) activated by 1 µM Fsk alone
(top) and by simultaneous
application of 1 µM Fsk together with 1 nM Iso
(bottom). Arrows, time of
application. Dashed line, 0-current level.
B: average steady-state density of
current activated by 1 µM Fsk (n = 21 myocytes) and 1 µM Fsk + 1 nM Iso
(n = 18 myocytes). Difference in
current density is statistically not significant
(P = 0.24).
C: normalized average activation time
course of ICl at
40 mV in response to rapid application at 0 time of 1 µM Fsk
(n = 10 myocytes) or simultaneous
application of 1 µM Fsk + 1 nM Iso
(n = 13 myocytes). Horizontal and
vertical lines, SDs in time and current density, respectively, at 50%
ICl activation. Difference in times of 50%
activation is statistically significant
(P = 0.0028).
Inset,
1/2 with 1 and 10 µM Fsk in
absence or presence of 1 nM Iso.
|
|
Figure 6A
shows time diaries of
ICl activated by
1 µM Fsk in the absence (top) or
presence (bottom) of 1 nM Iso after
inhibition of G protein activation by cell dialysis with 0.1 mM GDP
S
(3). Inhibition of G protein activation abolished the acceleration of
the 1 µM Fsk response by 1 nM Iso (Fig.
6B) but had little effect on the
activation time course and amplitude of
ICl activated by
Fsk alone (compare Fig. 6B with Fsk
responses in Fig. 5). This suggests that
1) the acceleration of the Fsk
response by low Iso is mediated by
-adrenoceptor-linked
Gs protein and
2) that basal G protein activity in
guinea pig ventricular myocytes does not significantly influence AC
stimulation by Fsk.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Low Iso-induced acceleration of
ICl activation by
Fsk in guinea pig ventricular myocytes is abolished by guanosine
5'-O-(2-thiodiphosphate)
(GDP S). A: chart recordings of
ICl (at 40
mV) activated by 1 µM Fsk alone
(top) and by simultaneous
application of 1 µM Fsk together with 1 nM Iso
(bottom) after cell dialysis with
GTP-free solution containing 0.1 mM GDP S. Arrows, time of
application. Dashed line, 0-current level.
B: normalized average activation time
course of ICl at
40 mV in response to rapid application at 0 time of 1 µM Fsk
(n = 6 myocytes) or 1 µM Fsk + 1 nM
Iso (n = 8 myocytes) after cell
dialysis with GTP-free solution containing 0.1 mM GDP S. Means ± SD at 50% deactivation are omitted for clarity because they were
virtually identical. Inset, average
steady-state magnitude of current activated by 1 µM Fsk alone or 1 µM Fsk + 1nM Iso after GDP S dialysis
(P = 0.018).
|
|
Effect of
-adrenoceptor-coupled
Gs on ICl
deactivation.
To further investigate whether Iso alters the responses of
ICl to Fsk
stimulation via effects on cell cAMP or via cAMP-independent pathways,
we tried to assess the cAMP level reached by stimulation with Fsk
and/or Iso by measuring
ICl deactivation.
Figure 7A
shows typical examples of
ICl deactivation
after stimulation and washout of Iso and Fsk alone or in combination.
Compared with 1 µM Fsk (Fig. 7A,
), ICl
deactivated somewhat faster when 1 µM Iso was used as the agonist
(Fig. 7A,
). This was due to a
shorter delay to the onset of current decay (56 ± 4 s; Fig.
7B,
left) as well as a shorter time to
half-maximal current decay (53 ± 9 s; Fig. 7B,
right). Current deactivation after
exposure to 1 µM Fsk + 1 nM Iso (Fig. 7A,
) was slightly faster
than with Fsk alone; however, on average, both the delay to the onset
of ICl decay (Fig. 7B,
left) and the time of half-maximal
current decay (Fig. 7B,
right) were not significantly
different from the values obtained with Fsk alone. After stimulation of
AC with 1 µM Iso + 1 µM Fsk (Fig.
7A,
),
ICl deactivation
was the slowest, mostly due to the prolonged delay to the onset of
ICl decay.
Indeed, the delay to the onset of
ICl decay (321 ± 42 s; Fig. 7B,
right) and the time of half-maximal
ICl decay (106 ± 21 s; Fig. 7B,
left) were similar to the values
observed with 10 µM Fsk (see Fig.
4B). Compared with the deactivation
time course with 1 µM Fsk, the most prominent alteration in the
deactivation kinetics of
ICl was a
prolongation of the delay to the onset of
ICl decay at
supramaximal levels of cAMP reached either by increasing the
concentration of Fsk to 10 µM (see Fig. 4) or by coapplication of 1 µM Iso. The decay of
ICl was
comparatively little affected by variations in agonist or agonist
concentration and seems to be less sensitive to changes in the
steady-state level of cAMP.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
Time course of
ICl deactivation
after stimulation with Iso and/or Fsk.
A: time course of
ICl deactivation
after withdrawal of 1 µM Iso, 1 µM Fsk, 1 µM Fsk + 1 nM Iso, and
1 µM Fsk + 1 µM Iso at 0 time.
ICl was measured
at +40 mV and normalized to
ICl density at
time of agonist withdrawal. B: average
delay between agonist withdrawal and onset of
ICl decay
(left) and average time of
half-maximal ICl
decay ( 1/2 measured from onset
of current decay; right) with 1 µM
Fsk (n = 5 myocytes), 1 µM Fsk + 1nM
Iso (n = 5 myocytes), 1 µM Fsk + 1 µM Iso (n = 7 myocytes), and 1 µM
Iso (n = 4 myocytes).
|
|
cAMP-activated ICl in cardiomyocytes from
different species.
We tried to determine whether similar differences in
ICl responses to
Fsk and Iso exist in cardiomyocytes from other tissues. Figure
8 demonstrates the effect of Iso (1 µM)
on holding current at
40 mV and
ICa at 0 mV in
cardiomyocytes from guinea pig ventricle (Fig.
8A) and atrium (Fig.
8B), rat ventricle (Fig.
8C), and frog ventricle (Fig.
8D). In all cell types, step
application of Iso increased
ICa by more than
twofold; however, Iso affected the holding current only in guinea pig
ventricular heart cells. These results confirm observations by others
(12) that cAMP-dependent ICl is not
ubiquitously present in mammalian cardiac tissue and show that it is
also absent in frog ventricle.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of Iso on holding current and
Ca2+ current
(ICa) in
enzymatically isolated cardiomyocytes from different species.
A-D,
left: chart recordings of
ICa and holding
current in guinea pig ventricle (A),
guinea pig atrium (B), rat ventricle
(C), and frog ventricle
(D). Membrane was held at 40
mV; ICa was
triggered by 40- (C) or 50-ms
(A,
B, and
D) voltage-clamp pulses to 0 mV
applied at 0.2 (A and
B) or 0.25 Hz
(C and
D). Arrows, step application of 1 µM Iso.
A-D,
right:
ICa as well as
short segments of holding current before and after depolarizing steps
at high resolution.
|
|
 |
DISCUSSION |
Responses of ICl to stimulation with Fsk.
The above results show that, in guinea pig ventricular myocytes, Fsk
affects ICl
activation time course and steady-state conductance in a dose-dependent
manner. The Hill coefficient of ~2 for the steep dose-conductance
curve (see Fig. 3B) is similar to
that determined with Iso (29) and might result from the stochiometry for PKA activation by cAMP; four cAMP molecules are required to liberate two catalytic subunits (28).
ICl activation
was markedly accelerated with increasing Fsk; however, even at
supramaximal Fsk concentrations,
ICl activated slower than after
-adrenoceptor stimulation with Iso (see Figs. 1B and
3C) or in response to flash
photolysis of caged cAMP under similar conditions (22). This indicates
that the stimulation of AC by Fsk is the rate-limiting step in
ICl activation.
Time lags for Fsk-induced increases in cAMP and a lower cAMP production early in the response have been observed with solubilized and membrane-bound AC in various preparations (27) and may account for the
considerable latency to current onset and the slow rate of
ICl activation.
The acceleration of
ICl activation
with increasing concentrations of Fsk should thus result from the
increased production of cAMP. Nakashima and Ono (22) found that the
activation of ICl
was also accelerated when increasing concentrations of cAMP were
produced by flash photolysis from caged compounds. Current activation
was ~1.4 times faster in response to cAMP elevations that elicited
~75% of the maximal Cl
conductance than in response to flashes that elicited ~35% of the
maximal conductance (see Fig. 4 in Ref. 22). Although Fsk-induced ICl activated
much slower in this study, increasing Fsk concentrations accelerated
the activation of
ICl to a similar
extent (see Fig. 3C). The
1/2 with 0.6 µM Fsk (75% of
maximal ICl)
was 1.3 times shorter than the
1/2 with 0.3 µM Fsk (35% of
maximal ICl).
This indicates that increasing concentrations of Fsk accelerate
ICl activation
through the same mechanism as does the photolysis of caged cAMP. Taken
together, it appears that although the stimulation of AC seems to be
the rate-limiting step in the activation of ICl, the
acceleration of
ICl activation
with increasing concentrations of Fsk results from processes downstream
of cAMP production, possibly, as suggested by Nakashima and Ono (22),
from an increase in the number of available (phosphorylated)
Cl
channels with increasing
concentrations of cAMP.
Effects of Gs activation by low Iso on
Fsk activation of ICl.
Activated G proteins modulate the Fsk stimulation of AC in various
preparations, usually by altering both the potency and efficacy of Fsk
(27); for example, activated Gi
protein inhibited the Fsk-induced activation of
ICl in guinea pig
ventricular myocytes (cf. Ref. 13). The inhibition seemed to result
from a decrease in the potency of Fsk. An increase in Fsk potency
and/or efficacy by activated
Gs protein (27) would enhance cAMP
production and could explain the acceleration of
ICl activation by
1 µM Fsk in the presence of 1 nM Iso (see Fig.
5C). If this explanation were correct, the increase in cAMP induced by 1 nM Iso should be similar to
that obtained by elevating the Fsk concentration from 1 to 10 µM
because coapplication of 1nM Iso accelerated the activation of
ICl to a similar
extent as did the elevation of Fsk from 1 to 10 µM (see Fig.
5C,
inset). Direct measurements of cAMP
levels in single cardiomyocytes are presently not possible; however, an
estimate of relative cAMP levels can be obtained by comparing the time
course of ICl
deactivation under both conditions. After stimulation and washout of 10 µM Fsk, ICl
deactivated significantly slower than with 1 µM Fsk (see Fig. 7).
This would indicate that AC stimulation with 10 µM Fsk elevates the
level of cAMP well above the saturating concentration achieved with 1 µM Fsk, which prolongs the delay to the onset of
ICl decay by the
time it takes for the 10 µM Fsk-induced cAMP level to decrease to the
level reached with 1 µM Fsk. In contrast, the coapplication of 1 nM Iso did not significantly affect the deactivation of 1 µM Fsk-induced ICl (see Fig. 7),
which argues against a significant increase in cell cAMP level on
Gs activation. This indicates that
a Gs-induced increase in Fsk
potency and/or efficacy cannot account for the effects of 1 nM
Iso on Fsk-induced
ICl.
Response of ICl to stimulation with Iso.
Several observations have led to the conclusion that the activation of
ICl by Iso
results exclusively from stimulation of the AC-cAMP-PKA pathway (cf.
Ref. 6). Most importantly, 1) ICl activation by
Iso was abolished when cAMP-dependent phosphorylation was inhibited
(see Fig. 1A; cf. Ref. 15) and
2) stimulation with Fsk or other
interventions that increase cellular cAMP levels occluded the effect of
Iso (see Fig. 1C; cf. Ref. 15).
However, when we compared
ICl densities in
response to
-adrenoceptor activation with Iso or AC stimulation with
Fsk under standardized conditions (high GTP-containing dialysates were
used to minimize current rundown and only responses to a first agonist
exposure were compared), we found that the maximal steady-state
ICl in response
to Iso (1 µM) was 1.6 times larger than that in response to 1 µM
Fsk (see Fig. 1C). We are not aware
of another study where
ICl densities in
response to
-adrenoceptor stimulation with Iso or AC stimulation with Fsk are compared, paying particular attention to the possible problems arising from repetitive agonist applications, i.e., current rundown or other desensitization processes. Hwang et al. (15), in
guinea pig ventricular myocytes at 36°C, also recorded an average ICl density in
response to 1 µM Iso [1.3 ± 0.5 (SE) µA/µF] that was 1.6 times larger than that in response to 1 µM Fsk (0.8 ± 0.1 µA/µF). Although this difference was not significant compared with
the large variations in current density with either agonist, the
similarity to our results is obvious.
Presently, we have no ready explanation for the detailed mechanism
underlying the difference in maximal steady-state current in response
to Iso or Fsk. Possible explanations are that
Gs protein activation by Iso
affects ICl by a
cAMP-independent stimulatory action and/or Fsk affects the
current by a cAMP-independent inhibitory action. Concerning the latter
possibility, we have recently shown that at high concentrations Fsk
directly inhibits
ICa in guinea pig
ventricular myocytes but not cAMP-dependent
ICl (1). This is
in keeping with the finding that the density and activation time course
of ICl activated
by simultaneous application of 1 µM Fsk and 1 µM Iso is
indistinguishable from current activated by Iso alone (data not shown).
Thus Gs protein may activate a cAMP-independent signaling pathway. This pathway does not activate ICl when
cAMP-dependent phosphorylation is prevented (Fig.
1Ab) but seems to assist in the
activation of ICl
by cAMP-dependent phosphorylation. Because the application of 1 µM
Iso subsequent to current activation with 1 µM Fsk had no further
stimulatory effect (Fig. 1C; cf. Ref.
15), we must assume that cAMP-independent signaling by
Gs selectively affects
unphosphorylated channels and/or that the action of
Gs is transient. The latter is
supported by the observation that
ICl stimulated
with 1 µM Iso displays a considerable rundown. The recordings in Fig.
1A show that 120 s after the
application of 1 µM Iso (Fig.
1Aa),
ICl density was similar to that observed 120 s after the stimulation with 1 µM Fsk
(Fig. 1Ad).
Although Gs activation by 1 nM Iso
was not sufficient to significantly increase the Fsk-induced
steady-state ICl
(see Fig. 5B), the acceleration of
the Fsk response by a cAMP-independent Gs pathway remains a distinct
possibility. In that regard, the nonhydrolyzable GTP analog guanosine
5'-O-(3-thiotriphosphate) accelerated ICl
activation induced by photolysis of caged cAMP in guinea pig
ventricular myocytes (18) even though guanosine 5'-O-(3-thiotriphosphate) seems
to preferentially activate Gi and
thus decreases AC activity (15) in these cells.
In conclusion, our results indicate that
1) the response of
ICl to Fsk
reflects the stimulation of cardiac AC,
2) modest activation of
-adrenoceptor-linked Gs protein
facilitates the effect of Fsk, and
3) strong activation of
Gs protein reveals a
cAMP-independent Gs signaling
pathway, which enhances the cAMP-mediated activation of
ICl.
 |
ACKNOWLEDGEMENTS |
We thank Darren J. Cole for technical assistance and Brian K. Hoyt
for unfailing technical and computer support.
 |
FOOTNOTES |
This work was supported by the New Brunswick Heart and Stroke
Foundation and by Salary Awards to S. Pelzer and D. J. Pelzer from the
Medical Research Council (Canada).
Y. M. Shuba was on leave from the A. A. Bogomoletz Institute of
Physiology, Ukrainian Academy of Sciences, 252024 Kiev, Ukraine.
Address reprint requests to S. Pelzer.
Received 2 October 1995; accepted in final form 24 July 1997.
 |
REFERENCES |
1.
Asai, T.,
S. Pelzer,
and
T. F. McDonald.
Cyclic AMP-independent inhibition of cardiac calcium current by forskolin.
Mol. Pharmacol.
50:
1262-1272,
1996[Abstract].
2.
Bahinski, A.,
A. C. Nairn,
P. Greengard,
and
D. C. Gadsby.
Chloride conductance regulated by cAMP-dependent protein kinase in cardiac myocytes.
Nature
340:
718-721,
1989[Medline].
3.
Birnbaumer, L., J. Codina, R. Mattera, A. Yatani, N. Scherer,
M.-J. Toro, and A. M. Brown. Signal transduction by G
proteins. Kidney Int. 32, Suppl.: S14-S37, 1987.
4.
Chang, F.,
I. S. Cohen,
D. DiFrancesco,
M. R. Rosen,
and
C. Tromba.
Effects of protein kinase inhibitors on canine Purkinje fiber pacemaker depolarization and the pacemaker current.
J. Physiol. (Lond.)
440:
367-384,
1991[Abstract/Free Full Text].
5.
Cohen, P.
Protein phosphorylation and hormone action.
Proc. R. Soc. Lond. B Biol. Sci.
234:
115-144,
1988[Medline].
6.
Gadsby, D. C.,
G. Nagel,
and
T.-C. Hwang.
The CFTR chloride channel of mammalian heart.
Annu. Rev. Physiol.
57:
387-416,
1995[Medline].
7.
Gilman, A. G.
G protein, transducers of receptor generated signals.
Annu. Rev. Biochem.
56:
615-649,
1987[Medline].
8.
Hamill, O. P.,
A. Marty,
E. Neher,
B. Sakmann,
and
F. J. Sigworth.
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch.
391:
85-100,
1981[Medline].
9.
Hartzell, H. C.
Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems.
Prog. Biophys. Mol. Biol.
52:
165-247,
1988[Medline].
10.
Harvey, R. D.,
and
J. R. Hume.
Autonomic regulation of a chloride current in heart.
Science
244:
983-985,
1989[Abstract/Free Full Text].
11.
Hume, J. R,
and
R. D. Harvey.
Chloride conductance pathways in heart.
Am. J. Physiol.
261 (Cell Physiol. 30):
C399-C412,
1991[Abstract/Free Full Text].
12.
Hume, J. R.,
and
B. Horowitz.
A plethora of cardiac chloride conductances: molecular diversity or a related gene family.
J. Cardiovasc. Electrophysiol.
6:
325-331,
1995[Medline].
13.
Hwang, T.-C.,
M. Horie,
A. T. Dousmanis,
and
D. C. Gadsby.
Interactive modulation of PKA-regulated chloride current by forskolin, Gs and Gi in guinea pig ventricular myocytes (Abstract).
Biophys. J.
61:
A395,
1992.
14.
Hwang, T.-C.,
M. Horie,
and
D. C. Gadsby.
Functionally different phospho-forms underlie incremental activation of protein kinase regulated Cl
conductance in mammalian heart.
J. Gen. Physiol.
101:
629-650,
1993[Abstract/Free Full Text].
15.
Hwang, T.-C.,
M. Horie,
A. C. Nairn,
and
D. C. Gadsby.
Role of GTP-binding proteins in the regulation of mammalian cardiac chloride conductance.
J. Gen. Physiol.
99:
465-489,
1992[Abstract/Free Full Text].
16.
Isenberg, G.,
and
U. Klöckner.
Calcium currents of isolated bovine ventricular myocytes are fast and of large amplitude.
Pflügers Arch.
395:
30-41,
1982[Medline].
17.
James, A. F.,
T. Tominaga,
Y. Okada,
and
M. Tominaga.
Distribution of cAMP-activated chloride current and CFTR mRNA in the guinea pig heart.
Circ. Res.
79:
201-207,
1996[Abstract/Free Full Text].
18.
Kozlowski, R. Z.,
L. J. Goodstadt,
V. W. Twist,
and
T. Powell.
Modulation of Cl
and L-type Ca2+ channels by GTP
S and photoreleased cAMP in isolated guinea-pig cardiac ventricular myocytes (Abstract).
J. Physiol. (Lond.)
459:
225P,
1993.
19.
Matsuoka, S.,
T. Ehara,
and
A. Noma.
Chloride-sensitive nature of the adrenaline-induced current in guinea pig cardiac myocytes.
J. Physiol. (Lond.)
425:
579-598,
1990[Abstract/Free Full Text].
20.
McDonald, T. F.,
S. Pelzer,
W. Trautwein,
and
D. J. Pelzer.
The regulation and modulation of calcium channels in cardiac, skeletal and smooth muscle.
Physiol. Rev.
74:
365-507,
1994[Free Full Text].
21.
Mitra, R.,
and
M. Morad.
A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates.
Am. J. Physiol.
249 (Heart Circ. Physiol. 18):
H1056-H1060,
1985.
22.
Nakashima, Y.,
and
K. Ono.
Rate-limiting step in activation of cardiac Cl
current revealed by photolytic application of cAMP.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H1514-H1522,
1994[Abstract/Free Full Text].
23.
Ono, K.,
T. Kiyosue,
and
M. Arita.
Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current.
Am. J. Physiol.
256 (Cell Physiol. 25):
C1131-C1137,
1989[Abstract/Free Full Text].
24.
Pelzer, S.,
Y. M. Shuba,
and
D. J. Pelzer.
Sympathetic stimulation of calcium current by cytoplasmic cAMP and direct
-adrenergic signal-transducing stimulatory G protein pathways in guinea pig and frog cardiomyocytes (Abstract).
J. Physiol. (Lond.)
459:
228P,
1993.
25.
Schubert, B. A.,
M. J. VanDongen,
G. E. Kirsch,
and
A. M. Brown.
-Adrenergic inhibition of cardiac sodium channels by dual G protein pathways.
Science
245:
516-519,
1989[Abstract/Free Full Text].
26.
Seamon, K. B.,
and
J. W. Daly.
Forskolin, cyclic AMP and cellular physiology.
Trends Pharmacol. Sci.
4:
120-123,
1983.
27.
Seamon, K. B.,
and
J. W. Daly.
Forskolin: its biological and chemical properties.
Adv. Cyclic Nucleotide Protein Phosphorylation Res.
20:
1-150,
1986[Medline].
28.
Talor, S. S.,
J. A. Buechler,
and
W. Yonemoto.
cAMP dependent protein kinase: framework for a diverse family of regulatory enzymes.
Annu. Rev. Biochem.
59:
971-1005,
1990[Medline].
29.
Tareen, F. M.,
K. Ono,
A. Noma,
and
T. Ehara.
-Adrenergic and muscarinic regulation of the chloride current in guinea-pig ventricular cells.
J. Physiol. (Lond.)
440:
225-241,
1991[Abstract/Free Full Text].
30.
Vandenberg, J. I.,
A. Yoshida,
K. Kirk,
and
T. Powell.
Swelling-activated and isoprenaline-activated chloride currents in guinea pig cardiac myocytes have distinct electrophysiology and pharmacology.
J. Gen. Physiol.
104:
997-101,
1994[Abstract/Free Full Text].
31.
Yatani, A.,
K. Okabe,
J. Codina,
L. Birnbaumer,
and
A. M. Brown.
Heart rate regulation by G proteins acting on the cardiac pacemaker channel.
Science
249:
1163-1166,
1990[Abstract/Free Full Text].
32.
Yazawa, K.,
and
M. Kameyama.
Mechanisms of receptor-mediated modulation of the delayed potassium outward current in guinea-pig ventricular myocytes.
J. Physiol. (Lond.)
421:
135-150,
1990[Abstract/Free Full Text].
33.
Wu, S.-N.,
J. Linden,
S. Visentin,
M. Boykin,
and
L. Belardinelli.
Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline.
Circ. Res.
65:
1066-1077,
1989[Abstract/Free Full Text].
AJP Heart Circ Physiol 273(6):H2539-H2548
0363-6135/97 $5.00
Copyright © 1997 the American Physiological Society